Posts by Marija Martini
Empowering digital transformation at L'Oréal with Discngine Assay cloud solution

Digital technologies are reshaping the landscape of discovery and innovation. L’Oréal has been leading the charge in embracing digital transformation and data-driven processes. Collaborating with Discngine, they've successfully migrated multiple of their scientific software applications to the cloud, enhancing research and innovation. Join us as we hear from project leaders Ludwig Baux and Diane Genest about their journey of migrating the screening assay data management software at L’Oréal.

Read More
How Sanofi scientists streamlined their in silico hazard assessment of potential genotoxic impurities by collaborating with Discngine

Sanofi assesses over 1000 potentially mutagenic or genotoxic impurities per year. Until recently, these assessments used to imply a lot of manual operations from its scientists. Alexander Amberg, Head of in silico toxicology, and Alain Grelier, Digital product owner, shared how we collaborated to drastically streamline the in silico hazard assessment of these impurities.

Read More
Structure-based lead optimization of a PROTAC small-molecule in the BRD4-CRBN complex

The purpose of this article is to illustrate how to apply some of 3decision’s features in scientific research. For this use case, the 3decision Subpocket Similarity Search is used to suggest modifications for the optimization of a small- molecule PROTAC. The Protein-Ligand interaction coloring by statistics is then used to evaluate docking poses of new compounds. The bromodomain-containing protein 4 – cereblon complex (BRD4-CBRN) and its degrader dBET23 are used as an example.

Read More
An innovative way of organizing data: How can 3decision® improve decision-making process? [Customer Success Story]

Manuel Cases Thomas, a Medicinal chemistry consultant and director at Senechaem was looking for a solution to help him use the full potential of data at hand and generate new design ideas. In this interview, he shares how 3decision® makes a difference in his daily work: from a scientific need to the impact on design ideas and successful project outcomes.

Read More
What are the challenges for medicinal chemists when working with 3D structures? - Interview

The continuous increase in the available 3D structural data brings along changes in the medicinal chemistry field. Dr. George Sheppard, Senior Principal Research Scientist at AbbVie, shared his thoughts on the benefits for medicinal chemists using 3D information, current challenges and limitations, and proposed potential ways for improvement, in the following interview.

Read More
Getting ready for AlphaFold with 3decision®

Google-owned company DeepMind has achieved to predict 3D protein shapes with high accuracy and speed using the AI program AlphaFold. Although still in the early phase, this method can have a significant impact on drug discovery, accelerating the development of new drugs. In this article, we are discussing the importance of getting ready for the new source of structural data and how to gain the most of structural knowledge.

Read More